Developer docs
API playgroundTry for free, no card

Search company profiles

Bio-Works

Full company profile

uuid0002oty

Namestring
Bio-Works
Legal namestring
Bio-Works Technologies AB
Websiteurl
bio-works.com
Company typeenum
Public
Founded yearint
2006
Descriptiontext

Bio-Works Technologies AB is a Swedish public company, founded in 2006 and headquartered in Uppsala, that designs, manufactures, and supplies agarose-based chromatography resins used in the purification of biopharmaceutical products. The company's core product platform is WorkBeads — porous agarose beads with a patented cross-linking process that delivers tight bead- and pore-size distribution — sold across affinity (including the WorkBeads affimAb Edge Protein A resin), ion exchange (IEX), immobilized metal affinity (IMAC), hydrophobic interaction (HIC), and size exclusion (SEC) chromatography modalities. The portfolio is completed by GoBio pre-packed process columns, BabyBio small-scale screening columns, and OptioBio development columns, covering the full workflow from research screening to GMP manufacturing. ISO 9001:2015 certified, with all R&D, production, and sales operations consolidated at a single Uppsala Fyrislund site.

Revenue is generated primarily through direct sales of bulk WorkBeads resin and GoBio pre-packed columns to biopharmaceutical and biotech customers, supplemented by a global distributor network that now includes Zenmindes Biotechnology for the Chinese market (partnership signed autumn 2025). Reported full-year 2025 net sales were SEK 62.5M, up from SEK 25.5M in 2024, with gross margins of 77% and 99% on-time delivery in 2024. Disclosed customers include Abera Bioscience, Nemysis, MDX, Miltenyi, and academic groups such as Jagiellonian University, alongside a returning European biopharma customer that placed a SEK 8.3M order for 69L of WorkBeads affimAb. Sales cycles are characteristically long at 3-5 years from initial development engagement through GMP commercial supply, and 15+ commercial drugs are reported to be purified using WorkBeads resins.

The company is led by CEO Lone Carlbom, is listed on the Spotlight Stock Market (also tradable on Frankfurt as fra:1BD), and operates with a small organizational footprint anchored in Uppsala. As of year-end 2025, Bio-Works held SEK 34.9M in cash, with management claiming full funding through to break-even (targeted for 2027), supported by capital raised via the TO 2 warrant series issued in August 2024 at SEK 1/share and subsequently exercised in tranches through early 2026.

Short descriptiontext

Bio-Works Technologies AB is a Swedish public manufacturer of next-generation agarose-based chromatography resins and pre-packed columns (WorkBeads, GoBio, BabyBio) for biopharmaceutical purification, serving biotech and biopharma customers from research through GMP manufacturing globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersUppsala, Sweden
HQ citystring
Uppsala
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
chromatography resins, biopharmaceutical purification, agarose-based resins, pre-packed columns, protein purification
Industry1 code
PRIMARYHLAAAJAF
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Bioprocessing Chromatography Resins
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Chromatography Resins and Pre-packed Columns
TypeHardware Sales
Description

Bio-Works generates revenue through the sale of chromatography resins (WorkBeads) and pre-packed columns (GoBio) for biomolecule purification. Products are sold directly and through distributors to biotech and biopharma customers globally. The company serves research-scale to industrial-scale production needs.

bio-works.com
2Warrants Exercise (TO 2)
TypeOne Time License
Description

Bio-Works raised SEK 17.85 million from warrant exercises in period 4 (October 2025), and SEK 1,199,471 from period 5 (January 2026). Each warrant exercises at SEK 1 per share. The company had approximately 17.5 million warrants still outstanding as of April 2026.

news.cision.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1WorkBeads
Description

Chromatography resins for purification of biomolecules including monoclonal antibodies, proteins, peptides, oligos, viruses and vaccines. Includes WorkBeads affimAb (Protein A affinity resin), WorkBeads 40Q/100Q (AIEX resins), WorkBeads 40S/100S (CIEX resins), WorkBeads NiMAC (IMAC), WorkBeads SEC (size exclusion), and WorkBeads 40 TREN (multimodal IEX).

bio-works.com
+3 more records
Core offering1 text field

Bio-Works designs, develops, manufactures and supplies next-generation agarose-based chromatography resins (WorkBeads) and pre-packed columns (GoBio, BabyBio, OptioBio) for the purification of biopharmaceuticals including monoclonal antibodies, proteins, peptides, oligonucleotides, viruses, and vaccines. The company serves customers from research scale through industrial GMP manufacturing, with a patented proprietary manufacturing process that produces porous beads with tight size and pore distribution.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Production capacity increased approximately 80% during 2025
+6 more records
Product overview1 text field

Bio-Works is a global manufacturer of next-generation agarose-based chromatography resins and pre-packed columns for purification of biopharmaceuticals. The product portfolio centers on WorkBeads™ chromatography resins (including affinity, IEX, IMAC, HIC, SEC, and activated resins), complemented by GoBio™ and BabyBio™ pre-packed column lines. The company offers standard resin formats as well as custom resin solutions, serving customers from research scale to industrial GMP manufacturing. The WorkBeads affimAb Edge represents their latest-generation Protein A resin for antibody purification.

Product and service1 record
1WorkBeads Affinity Chromatography Resins
Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Zenmindes Biotechnology Co., Ltd.
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-09-01
Description

Strategic partnership signed in autumn 2025 to establish a strong and sustainable presence in China's rapidly expanding biopharmaceutical market. Zenmindes has deep understanding of the complex purification needs of local markets and helps get Bio-Works involved earlier in customers' development phases, accelerating the typically long 3-5 year sales cycle in biopharma.

bio-works.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cytiva (formerly GE Healthcare Life Sciences) is the global market leader in chromatography resins for bioprocessing, with flagship Protein A resins (MabSelect) and a full IEX/IMAC/SEC/HIC portfolio. Cytiva is the most direct competitor to Bio-Works in WorkBeads' target applications, particularly mAb purification and commercial-scale biomanufacturing.

TypeDirect peer
Description

Tosoh Bioscience manufactures Toyopearl and TSKgel chromatography resins widely used in biopharmaceutical purification, including IEX, HIC, SEC, and affinity modes. Tosoh is a direct competitor to Bio-Works in process-scale resin supply, particularly in Asia where both companies compete for biopharma purification share.

3Merck KGaA (Life Science / MilliporeSigma)
TypeBroad incumbent
Description

Merck's Life Science sector (MilliporeSigma) supplies Eshmuno and ProSep chromatography resins alongside a much broader bioprocessing and lab products portfolio. As a broad incumbent with deep customer relationships across biopharma, Merck competes with Bio-Works in chromatography resins while also offering end-to-end process solutions that Bio-Works does not.

TypeDirect peer
Description

Bio-Rad manufactures chromatography resins including UNOsphere, Nuvia, and Macro-Prep product lines for protein and biomolecule purification. Bio-Rad's process chromatography business directly overlaps with Bio-Works' WorkBeads portfolio across IEX, affinity, and SEC modes for research-to-process scale applications.

TypeDirect peer
Description

Repligen is a pure-play bioprocessing specialist whose AVIPure Protein A resins and OPUS pre-packed columns compete directly with WorkBeads affimAb and GoBio in mAb and bispecific antibody purification. Repligen's focus on chromatography and bioprocess solutions makes it a particularly close comparable for Bio-Works' commercial strategy.

TypeBroad incumbent
Description

Sartorius is a major bioprocess equipment and consumables supplier whose Sartobind and CIMmultus membrane chromatography products compete in biomolecule purification. Sartorius' broad bioprocessing portfolio (upstream + downstream + fill-finish) and large installed base in commercial biomanufacturing make it a broad incumbent competitor to Bio-Works in process chromatography.

TypeBroad incumbent
Description

Thermo Fisher's bioproduction and chromatography offering includes POROS resins, CaptureSelect affinity ligands, and a broad life sciences portfolio. While Bio-Works competes specifically against the chromatography product lines, Thermo Fisher's global scale and bundling across instruments, consumables, and services create significant competitive pressure in commercial-scale accounts.

TypeDirect peer
Description

Purolite launched the Praesto range of agarose-based chromatography resins in 2018 specifically targeting bioprocessing. As a relatively newer direct entrant into bioprocess chromatography with comparable agarose bead technology, Purolite is one of the closest direct competitors to Bio-Works' WorkBeads in mAb and protein purification.

TypeBroad incumbent
Description

Avantor distributes and supplies chromatography resins and bioprocessing consumables globally to biopharma manufacturers, including J.T.Baker and own-brand chromatography products. Avantor's broad product distribution and global scale make it a relevant incumbent competitor in the same end-customer accounts that Bio-Works targets.

TypeBroad incumbent
Description

Agilent Technologies supplies chromatography products including Bio-Monolith and CrossLab bioprocess solutions, alongside a broader analytical instruments and life sciences portfolio. Agilent is a relevant broad incumbent with overlapping chromatography capability, particularly in analytical and small-scale purification adjacencies to Bio-Works' process-scale resins.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bio-Works

Bioprocessing Chromatography Resinsbio-works.com

Bio-Works Technologies AB is a Swedish public manufacturer of next-generation agarose-based chromatography resins and pre-packed columns (WorkBeads, GoBio, BabyBio) for biopharmaceutical purification, serving biotech and biopharma customers from research through GMP manufacturing globally.

What Bio-Works does

Bio-Works Technologies AB is a Swedish public company, founded in 2006 and headquartered in Uppsala, that designs, manufactures, and supplies agarose-based chromatography resins used in the purification of biopharmaceutical products. The company's core product platform is WorkBeads — porous agarose beads with a patented cross-linking process that delivers tight bead- and pore-size distribution — sold across affinity (including the WorkBeads affimAb Edge Protein A resin), ion exchange (IEX), immobilized metal affinity (IMAC), hydrophobic interaction (HIC), and size exclusion (SEC) chromatography modalities. The portfolio is completed by GoBio pre-packed process columns, BabyBio small-scale screening columns, and OptioBio development columns, covering the full workflow from research screening to GMP manufacturing. ISO 9001:2015 certified, with all R&D, production, and sales operations consolidated at a single Uppsala Fyrislund site.

Revenue is generated primarily through direct sales of bulk WorkBeads resin and GoBio pre-packed columns to biopharmaceutical and biotech customers, supplemented by a global distributor network that now includes Zenmindes Biotechnology for the Chinese market (partnership signed autumn 2025). Reported full-year 2025 net sales were SEK 62.5M, up from SEK 25.5M in 2024, with gross margins of 77% and 99% on-time delivery in 2024. Disclosed customers include Abera Bioscience, Nemysis, MDX, Miltenyi, and academic groups such as Jagiellonian University, alongside a returning European biopharma customer that placed a SEK 8.3M order for 69L of WorkBeads affimAb. Sales cycles are characteristically long at 3-5 years from initial development engagement through GMP commercial supply, and 15+ commercial drugs are reported to be purified using WorkBeads resins.

The company is led by CEO Lone Carlbom, is listed on the Spotlight Stock Market (also tradable on Frankfurt as fra:1BD), and operates with a small organizational footprint anchored in Uppsala. As of year-end 2025, Bio-Works held SEK 34.9M in cash, with management claiming full funding through to break-even (targeted for 2027), supported by capital raised via the TO 2 warrant series issued in August 2024 at SEK 1/share and subsequently exercised in tranches through early 2026.

Bio-Works firmographics

Firmographics
Name
Bio-Works
Legal name
Bio-Works Technologies AB
Website
https://bio-works.com
Company type
Public
Founded year
2006
Operating status
Operating
Headcount range
51–100 employees
Short description
Bio-Works Technologies AB is a Swedish public manufacturer of next-generation agarose-based chromatography resins and pre-packed columns (WorkBeads, GoBio, BabyBio) for biopharmaceutical purification, serving biotech and biopharma customers from research through GMP manufacturing globally.
Ownership category
akta.pro rank

Bio-Works industry classification

Industry
Product category
Bioprocessing Chromatography Resins
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAAAJAF
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Chromatography resins
  • Biopharmaceutical purification
  • Agarose-based resins
  • Pre-packed columns
  • Protein purification

Where Bio-Works is headquartered

Location

Headquarters

HQ city
Uppsala
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

Bio-Works business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Chromatography Resins and Pre-packed Columns: Bio-Works generates revenue through the sale of chromatography resins (WorkBeads) and pre-packed columns (GoBio) for biomolecule purification. Products are sold directly and through distributors to biotech and biopharma customers globally. The company serves research-scale to industrial-scale production needs.
  2. Warrants Exercise (TO 2): Bio-Works raised SEK 17.85 million from warrant exercises in period 4 (October 2025), and SEK 1,199,471 from period 5 (January 2026). Each warrant exercises at SEK 1 per share. The company had approximately 17.5 million warrants still outstanding as of April 2026.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Bio-Works product offering

Product offering

Core offering

Bio-Works designs, develops, manufactures and supplies next-generation agarose-based chromatography resins (WorkBeads) and pre-packed columns (GoBio, BabyBio, OptioBio) for the purification of biopharmaceuticals including monoclonal antibodies, proteins, peptides, oligonucleotides, viruses, and vaccines. The company serves customers from research scale through industrial GMP manufacturing, with a patented proprietary manufacturing process that produces porous beads with tight size and pore distribution.

Product overview

Bio-Works is a global manufacturer of next-generation agarose-based chromatography resins and pre-packed columns for purification of biopharmaceuticals. The product portfolio centers on WorkBeads™ chromatography resins (including affinity, IEX, IMAC, HIC, SEC, and activated resins), complemented by GoBio™ and BabyBio™ pre-packed column lines. The company offers standard resin formats as well as custom resin solutions, serving customers from research scale to industrial GMP manufacturing. The WorkBeads affimAb Edge represents their latest-generation Protein A resin for antibody purification.

Differentiator

Problem solved

Functional benefit

Brands

  • WorkBeads: Chromatography resins for purification of biomolecules including monoclonal antibodies, proteins, peptides, oligos, viruses and vaccines. Includes WorkBeads affimAb (Protein A affinity resin), WorkBeads 40Q/100Q (AIEX resins), WorkBeads 40S/100S (CIEX resins), WorkBeads NiMAC (IMAC), WorkBeads SEC (size exclusion), and WorkBeads 40 TREN (multimodal IEX).
  • GoBio
  • BabyBio
  • OptioBio

Products and services

  • WorkBeads Affinity Chromatography Resins

Quantifiable outcome

  • Production capacity increased approximately 80% during 2025
  • +6 more outcomes

Companies that use Bio-Works

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Bio-Works technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Bio-Works partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Zenmindes Biotechnology Co., Ltd.coreChannel Partner/ Reseller/ Distributor · 1 September 2025Strategic partnership signed in autumn 2025 to establish a strong and sustainable presence in China's rapidly expanding biopharmaceutical market. Zenmindes has deep understanding of the complex purification needs of local markets and helps get Bio-Works involved earlier in customers' development phases, accelerating the typically long 3-5 year sales cycle in biopharma.

Scale indicators13 records

Recent moves5 records

Expansion highlights4 records

Bio-Works competitors and assessment

Company assessment

Direct peers

  • Cytiva: Cytiva (formerly GE Healthcare Life Sciences) is the global market leader in chromatography resins for bioprocessing, with flagship Protein A resins (MabSelect) and a full IEX/IMAC/SEC/HIC portfolio. Cytiva is the most direct competitor to Bio-Works in WorkBeads' target applications, particularly mAb purification and commercial-scale biomanufacturing.
  • Tosoh Bioscience: Tosoh Bioscience manufactures Toyopearl and TSKgel chromatography resins widely used in biopharmaceutical purification, including IEX, HIC, SEC, and affinity modes. Tosoh is a direct competitor to Bio-Works in process-scale resin supply, particularly in Asia where both companies compete for biopharma purification share.
  • Bio-Rad Laboratories: Bio-Rad manufactures chromatography resins including UNOsphere, Nuvia, and Macro-Prep product lines for protein and biomolecule purification. Bio-Rad's process chromatography business directly overlaps with Bio-Works' WorkBeads portfolio across IEX, affinity, and SEC modes for research-to-process scale applications.
  • Repligen Corporation: Repligen is a pure-play bioprocessing specialist whose AVIPure Protein A resins and OPUS pre-packed columns compete directly with WorkBeads affimAb and GoBio in mAb and bispecific antibody purification. Repligen's focus on chromatography and bioprocess solutions makes it a particularly close comparable for Bio-Works' commercial strategy.
  • Purolite (an Ecolab company): Purolite launched the Praesto range of agarose-based chromatography resins in 2018 specifically targeting bioprocessing. As a relatively newer direct entrant into bioprocess chromatography with comparable agarose bead technology, Purolite is one of the closest direct competitors to Bio-Works' WorkBeads in mAb and protein purification.

Broad incumbents

  • Merck KGaA (Life Science / MilliporeSigma): Merck's Life Science sector (MilliporeSigma) supplies Eshmuno and ProSep chromatography resins alongside a much broader bioprocessing and lab products portfolio. As a broad incumbent with deep customer relationships across biopharma, Merck competes with Bio-Works in chromatography resins while also offering end-to-end process solutions that Bio-Works does not.
  • Sartorius AG: Sartorius is a major bioprocess equipment and consumables supplier whose Sartobind and CIMmultus membrane chromatography products compete in biomolecule purification. Sartorius' broad bioprocessing portfolio (upstream + downstream + fill-finish) and large installed base in commercial biomanufacturing make it a broad incumbent competitor to Bio-Works in process chromatography.
  • Thermo Fisher Scientific: Thermo Fisher's bioproduction and chromatography offering includes POROS resins, CaptureSelect affinity ligands, and a broad life sciences portfolio. While Bio-Works competes specifically against the chromatography product lines, Thermo Fisher's global scale and bundling across instruments, consumables, and services create significant competitive pressure in commercial-scale accounts.
  • Avantor: Avantor distributes and supplies chromatography resins and bioprocessing consumables globally to biopharma manufacturers, including J.T.Baker and own-brand chromatography products. Avantor's broad product distribution and global scale make it a relevant incumbent competitor in the same end-customer accounts that Bio-Works targets.
  • Agilent Technologies: Agilent Technologies supplies chromatography products including Bio-Monolith and CrossLab bioprocess solutions, alongside a broader analytical instruments and life sciences portfolio. Agilent is a relevant broad incumbent with overlapping chromatography capability, particularly in analytical and small-scale purification adjacencies to Bio-Works' process-scale resins.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Bio-Works social profiles

Digital presence

Bio-Works compliance and trust

Trust signal

Compliance1 record

Bio-Works financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bio-Works leadership team

Management profile

Number of profiles

Profiles2 records

Bio-Works funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bio-Works M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bio-Works

What does Bio-Works do?

Bio-Works designs, develops, manufactures and supplies next-generation agarose-based chromatography resins (WorkBeads) and pre-packed columns (GoBio, BabyBio, OptioBio) for the purification of biopharmaceuticals including monoclonal antibodies, proteins, peptides, oligonucleotides, viruses, and vaccines. The company serves customers from research scale through industrial GMP manufacturing, with a patented proprietary manufacturing process that produces porous beads with tight size and pore distribution.

Is Bio-Works a public or private company?

Bio-Works is a public company. It is classified as public and is currently operating.

When was Bio-Works founded?

Bio-Works was founded in 2006. It employs 51 to 100 people.

Where is Bio-Works based?

Bio-Works is headquartered in Uppsala, Sweden, in the Europe region.

How does Bio-Works make money?

Two revenue lines are on record. Chromatography Resins and Pre-packed Columns are the primary driver. The others are warrants Exercise (TO 2).

Who are Bio-Works's main competitors?

Direct peers on record are Cytiva, Tosoh Bioscience, Bio-Rad Laboratories, Repligen Corporation and Purolite (an Ecolab company). Broad incumbents are Merck KGaA (Life Science / MilliporeSigma), Sartorius AG, Thermo Fisher Scientific, Avantor and Agilent Technologies.

Does Bio-Works have an API?

No public API is recorded for Bio-Works.

What industry is Bio-Works in?

Bio-Works's product category is Bioprocessing Chromatography Resins. Its primary akta.pro industry code is HLAAAJAF, Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling). Its NAICS code is 334516 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
news.cision.comBio-Works Receives Order from Returning CustomerBio-Works Technologies AB received a new order worth 8 MSEK from a returning customer for its chromatography products. The order is part of strengthening the collaboration and will be delivered during Q1 2027.TradingViewBio-Works Technologies: Nine-month sales advanced, Q3 weakened, and strong orders build the future delivery pipelineBio-Works Technologies reported nine-month sales up 52% year-over-year, with operating loss narrowing, while Q3 revenue and earnings weakened due to lower deliveries. Q3 order intake rose sharply, and several large orders are scheduled for future delivery.The future of tradingBio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 8 of 11Bio-Works Technologies AB announced that 558,776 warrants of series TO 2 were exercised during the eighth exercise period, resulting in 558,776 new shares at SEK 1 each. The company received SEK 558,776 before issue costs, and the next exercise period is 4-18 January 2027.The future of tradingBio-Works Raises SEK 558,776 From Warrant ExerciseBio-Works Technologies raised SEK 558,776 from the exercise of 558,776 warrants at SEK 1 per share. The exercise creates 558,776 new shares, bringing total shares to 100,972,656 and diluting nonparticipating shareholders by about 0.55%. The next exercise period runs January 4-18, 2027.news.cision.comBio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 8 of 11Bio-Works Technologies AB announced that 558,776 warrants of series TO 2 were exercised during the eighth exercise period, subscribing for 558,776 new shares at SEK 1 each. The company received SEK 558,776 before issue costs, and the next exercise period is 4–18 January 2027.news.cision.comBio-Works Technologies AB - Business Update third quarter 2026Bio-Works Technologies reported Q3 2026 net sales of 9.7 MSEK, down from 16.6 MSEK in the prior quarter, with order intake of 40.8 MSEK. The company's order-book as of September 30, 2026, stood at 38.1 MSEK. The figures are preliminary, and the company is in a growth phase.news.cision.comToday is the first day of the eighth exercise period for Bio-Works Technologies AB's warrants of series TO 2Bio-Works Technologies AB began its eighth exercise period for warrants of series TO 2 on 1 October 2026, running until 14 October. Of 38,979,790 warrants issued, 22,454,300 have been exercised, leaving 16,525,490 outstanding. Full exercise would increase shares by 16,525,490 and dilute capital by about 14.1%.news.cision.comBio-Works brings forward the publication of its interim report for the third quarter of 2026Bio-Works moved the publication of its Q3 2026 interim report from 6 November to 30 October 2026. The change follows Eva Lindskog's appointment as CEO on 1 November, so the report will be issued under Lone Carlbom, who held operational responsibility.MarketScreenerBio-Works Technologies Secures Medicine Development Deal with US Biotech CompanyBio-Works Technologies AB is a Sweden-based biotechnology company that designs, develops, and supplies protein purification and separation products. Its offerings include WorkBeads, BabyBio, and OptioBio, using agarose beads for liquid chromatography. The company employs 33 people and operates in biopharma, life science, and food and beverage sectors.news.cision.comBio-Works Secures New US Customer in the Development of Next-Generation MedicineBio-Works Technologies AB announced a US biotechnology partner selected it for a new medicine development project, with an order valued at SEK 2.8 million. The collaboration uses Bio-Works' purification products and expertise, and the project's growth depends on drug development progress.